Log In
Print this Print this

Supprelin LA, histrelin

Also known as: VP002

  Manage Alerts
Collapse Summary General Information
Company Endo International plc
DescriptionImplant to deliver synthetic nonapeptide agonist of GnRH/LHRH receptor over a 12-month period
Molecular Target GnRH/LHRH receptor
Mechanism of ActionGnRH/LHRH receptor agonist
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentMarketed
Standard IndicationPrecocious puberty
Indication DetailsTreat central precocious puberty (CPP)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today